Tissue Repair Ltd (ASX: TRP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Tissue Repair Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$11.19 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
60.46 million
Earnings per share
-0.070
Dividend per share
N/A
Year To Date Return
-51.95%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Tissue Repair Ltd (ASX: TRP)
Latest News
Healthcare Shares
2 ASX biotech shares rocketing more than 40% on big news
IPOs
IPO flop: Tissue Repair (ASX:TRP) share price plunges 40% since listing
TRP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Tissue Repair Ltd
Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.
TRP Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 06 Feb 2026 | $0.19 | $-0.02 | -9.76% | 39,590 | $0.20 | $0.20 | $0.19 |
| 05 Feb 2026 | $0.21 | $0.00 | 0.00% | 113,260 | $0.20 | $0.23 | $0.20 |
| 04 Feb 2026 | $0.21 | $0.01 | 5.13% | 237,603 | $0.20 | $0.21 | $0.19 |
| 03 Feb 2026 | $0.20 | $-0.01 | -5.00% | 143,769 | $0.20 | $0.21 | $0.20 |
| 02 Feb 2026 | $0.20 | $0.00 | 0.00% | 939,464 | $0.21 | $0.21 | $0.17 |
| 30 Jan 2026 | $0.21 | $-0.11 | -35.48% | 1,029,020 | $0.31 | $0.31 | $0.20 |
| 29 Jan 2026 | $0.31 | $0.01 | 3.28% | 12,000 | $0.32 | $0.32 | $0.31 |
| 28 Jan 2026 | $0.31 | $-0.02 | -6.25% | 113,276 | $0.32 | $0.32 | $0.31 |
| 27 Jan 2026 | $0.32 | $-0.01 | -3.08% | 106,802 | $0.33 | $0.33 | $0.31 |
| 23 Jan 2026 | $0.33 | $-0.02 | -5.88% | 76,105 | $0.34 | $0.34 | $0.32 |
| 22 Jan 2026 | $0.34 | $0.02 | 6.25% | 40,707 | $0.33 | $0.35 | $0.33 |
| 21 Jan 2026 | $0.32 | $-0.01 | -3.08% | 64,285 | $0.33 | $0.34 | $0.32 |
| 20 Jan 2026 | $0.33 | $-0.01 | -2.99% | 22,782 | $0.33 | $0.34 | $0.32 |
| 19 Jan 2026 | $0.34 | $0.00 | 0.00% | 84,880 | $0.33 | $0.34 | $0.32 |
| 16 Jan 2026 | $0.34 | $0.01 | 3.08% | 41,933 | $0.33 | $0.34 | $0.32 |
| 15 Jan 2026 | $0.33 | $-0.01 | -3.03% | 81,676 | $0.33 | $0.34 | $0.33 |
| 14 Jan 2026 | $0.33 | $-0.01 | -2.94% | 342,062 | $0.34 | $0.34 | $0.32 |
| 13 Jan 2026 | $0.34 | $0.01 | 2.99% | 10,586 | $0.36 | $0.36 | $0.34 |
| 12 Jan 2026 | $0.34 | $-0.03 | -8.22% | 192,574 | $0.36 | $0.36 | $0.34 |
| 09 Jan 2026 | $0.37 | $-0.01 | -2.67% | 73,512 | $0.38 | $0.38 | $0.36 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 26 Nov 2025 | Alistair McKeough | Buy | 30,000 | $8,775 |
On-market trade.
|
| 26 Nov 2025 | Alistair McKeough | Issued | 311,000 | $88,635 |
Issue of options.
|
| 26 Nov 2025 | Patryk Kania | Issued | 261,000 | $74,385 |
Issue of options.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Tony Charara | Co-FounderExecutive Director | May 2012 |
Mr Charara is an investment banker by background with JPMorgan. Tony is also a co-founder of Mable Technologies, and the Attain Healthtech group Australia's health services online platform in the aged care and disability markets processing around $1b annually in heathcare funds.
|
| Mr Alistair Gregory McKeough | Non-Executive Director | Oct 2024 |
Mr McKeough is experienced executive. Over the last 20 years he has worked with some of Australia's entrepreneurs, helping them through all stages of founding, growing, scaling, funding and then selling their businesses. Alistair has experience running and leading a variety of private and listed corporations in sectors, including professional services, technology, financial services, charities, health, biotech, childcare and education. Alistair has a track record in crisis management, including in media sensitive matters, and in navigating complex commercial situations that require careful strategic planning.
|
| Mr Patryk Kania | Non-Executive Director | Oct 2024 |
Mr Kania is a medical device executive with over 20 years of commercialisation and leadership experience in medical devices, pharma, and health technologies working across the US, Europe and APAC, within sales and marketing management, and general management roles. Currently, Patryk is CEO and President USA of Field Orthopaedics Ltd. and has previously held senior roles at Smith+Nephew, Abbott, J&J Medical and Roche.
|
| Ms Sushma Kejriwal | Company Secretary | Mar 2024 |
-
|
| Sushma Kejriwal | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Selene Holdings Ltd | 5,955,980 | 9.85% |
| Spark Capital Pty Limited | 4,822,260 | 7.98% |
| Hishenk Pty Ltd | 3,990,000 | 6.60% |
| Creight Investments Pty Ltd | 3,031,720 | 5.01% |
| Welas Pty Ltd <Wales Family Trust A/C> | 2,317,580 | 3.83% |
| Mark Deacon Shaw | 2,035,160 | 3.37% |
| Bannaby Investments Pty Limited | 1,690,580 | 2.80% |
| Moore Family Nominee Pty Limited | 1,217,400 | 2.01% |
| Mr Guy Banducci & Mrs Lisa Maree Banducci <Kali Super Fund A/C> | 1,170,000 | 1.94% |
| Mr Aaron Mark Deacon Shaw | 1,079,186 | 1.78% |
| Gidley Baird Holdings Pty Ltd <Gidley Baird Superfund A/C> | 1,055,440 | 1.75% |
| Bide Family Pty Ltd <Bide Family A/C> | 1,000,000 | 1.65% |
| Creight Investments Pty Ltd <Scutt Jacob Retirement Fund> | 990,540 | 1.64% |
| Warwick Nettle Pty Limited <Warwick Nettle Superannuationfund A/C> | 967,040 | 1.60% |
| Super Secret Pty Limited <Tkocz Sf A/C> | 800,000 | 1.32% |
| Citicorp Nominees Pty Limited | 648,991 | 1.07% |
| Dc Scutt Pty Ltd <Dcs Pension A/C> | 642,095 | 1.06% |
| Cinderella Management Company Pty Ltd <The Cinderella Unit A/C> | 608,694 | 1.01% |
| Rg Roden Pty Limited | 608,680 | 1.01% |
| Bmy Group Pty Ltd | 543,478 | 0.90% |
